Plasma transthyretin is a nutritional biomarker in human morbidities

Abstract

Transthyretin (TTR) is a small liver-secreted plasma protein that shows close correlations with changes in lean body mass (LBM) during the entire human lifespan and agglomerates the bulk of nitrogen (N)-containing substrates, hence constituting the cornerstone of body building. Amino acids (AAs) dietary restriction causes inhibition of TTR production and impairs the accretion of LBM reserves. Inflammatory disorders result in cytokine-induced abrogation of TTR synthesis and urinary leakage of nitrogenous catabolites. Taken together, the data indicate that malnutrition and inflammation may similarly suppress the production of TTR through distinct and unrelated pathophysiological mechanisms while operating in concert to downsize LBM stores. The hepatic synthesis of TTR integrates both machineries, acting as a marker of reduced LBM resources still available for defense and repair processes. TTR operates as a universal surrogate analyte that allows for the grading of residual LBM capacity to reflect disease burden. Measurement of TTR is a simple, rapid, and inexpensive micro-method that may be reproduced on a daily basis, hence ideally suited for the follow-up of the most intricated clinical situations and as a reliable predictor of any morbidity outcome.

Serum protein profiling reveals mechanism of activated thrombus formation in patients with stroke and atrial fibrillation

“…A1AG1 is an acute-phase protein produced in the www.nature.com/scientificreports/ liver and peripheral tissues in response to systemic conditions 6,7 . Ultimately, the decreased serum concentration of TTR is due to the inflammation response [8][9][10] .…”

Identification of modules and key genes associated with breast cancer subtypes through network analysis

“…When endothelial cells are treated with TTR , there's a suppression of T cell proliferation 125 linking it to disease pathologies and marking www.nature.com/scientificreports/ it as Oxidative Stress Biomarker 126 . Additionally, the inhibition of TTR , associated with conditions such as malnutrition and inflammation, is recognized as a biomarker for various human morbidities 127 . www.nature.com/scientificreports/ Finally, the network for the subtype HER2 ampl consists of 50 nodes and 162 edges with a threshold of 0.0211.…”

Identification of modules and key genes associated with Breast Cancer subtypes through network analysis

“…Endothelial cells treated with TTR suppress T cell proliferation 59 linked to speci c disease pathologies are considered an Oxidative Stress Biomarker 101 . Regarded their inhibition as malnutrition and in ammation used as a biomarker for human morbidities 52 .…”